Intern- Commercial- Learning and Development (L&D) at Gilead Sciences

Foster City, California, United States

Gilead Sciences Logo
Not SpecifiedCompensation
InternshipExperience Level
InternshipJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

  • Must be at least 18 years old
  • Must have a minimum GPA of 2.8
  • Authorized to work in the United States without sponsorship now or in the future or CPT/OPT through your University
  • Must be currently enrolled as a full-time student in a Bachelor’s/Masters/MBA/PhD program at an accredited US based university or college
  • Must be a Rising Sophomore, Junior, or Senior in undergrad or a Graduate or Doctoral Student
  • Must be enrolled full-time in the Fall Semester at an accredited university/college after the completion of the internship
  • Must be able to complete a 10-12 consecutive week internship between May and August
  • Must be able to relocate if necessary and work at the designated site for the duration of the internship
  • Preferred Qualifications
  • Preferred Degree qualification: MS (Computer Science or Similar) or MBA w/STEM (computer science or similar) undergraduate degree
  • Proficiency with MS Office Suite
  • Ability to identify issues and seek solutions
  • Ability to work both independently and collaboratively
  • Demonstrated commitment to inclusion and diversity in the workplace
  • Efficient, organized, and able to handle short timelines in a fast-paced environment
  • Familiarity with AI agent development concepts, including task-based agents
  • Exposure to AI platforms like Copilot Studio, etc., as these are core tools for building and deploying intelligent agents
  • Understanding of automation workflows, decision-support systems, and personalization techniques for user experiences

Responsibilities

  • Explore AI agent capabilities to support learning and coaching workflows across commercial L&D platforms such as LMS systems, AI Coaching Applications, and Copilot Studio
  • Map and analyze Gilead’s learning technology ecosystem, including LMS systems, to identify integration opportunities and system dependencies to recommend impactful next steps
  • Support alignment efforts between AI tools and existing learning applications by documenting use cases, data flows, and system touchpoints
  • Collaborate with cross-functional teams (e.g., Learning Technology, Commercial Ops, Sales and Marketing Excellence, IT, GDI) to gather insights and requirements for scalable AI integration
  • Showcase your work with a final presentation (PPT) near the conclusion of your internship

Skills

AI agents
LMS systems
AI Coaching Applications
Copilot Studio
learning technology
integration
learning and development

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI